BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 15980403)

  • 1. The Expression of Antibiotic Resistance Methyltransferase Correlates with mRNA Stability Independently of Ribosome Stalling.
    Dzyubak E; Yap MN
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7178-7188. PubMed ID: 27645242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to Macrolide Antibiotics in Public Health Pathogens.
    Fyfe C; Grossman TH; Kerstein K; Sutcliffe J
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27527699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae.
    Camilli R; Del Grosso M; Iannelli F; Pantosti A
    Antimicrob Agents Chemother; 2008 Feb; 52(2):619-25. PubMed ID: 18070957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies.
    Silva-Costa C; Friães A; Ramirez M; Melo-Cristino J
    Expert Rev Anti Infect Ther; 2015 May; 13(5):615-28. PubMed ID: 25746210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics.
    Roberts MC
    Mol Biotechnol; 2004 Sep; 28(1):47-62. PubMed ID: 15456963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the DNA sequences in the upstream attenuator region of erm(A) in clinical isolates of Streptococcus pyogenes and their correlation with macrolide/lincosamide resistance.
    Doktor SZ; Shortridge V
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3070-2. PubMed ID: 15980403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
    Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
    J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study on erm(B)-mediated MLS resistance in Streptococcus pyogenes clinical isolates.
    Rombini S; Petrelli D; Bolli E; Tran CN; Falconi M; Di Luca MC; Prenna M; Ripa S; Vitali LA
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):387-94. PubMed ID: 21683270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
    Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of plasmid-borne erm(T) macrolide resistance in group B and group A Streptococcus.
    DiPersio LP; DiPersio JR; Beach JA; Loudon AM; Fuchs AM
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):217-23. PubMed ID: 21899978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
    Bley C; van der Linden M; Reinert RR
    Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of emm typing and ribotyping with three restriction enzymes to characterize clinical isolates of Streptococcus pyogenes.
    Doktor SZ; Beyer JM; Flamm RK; Shortridge VD
    J Clin Microbiol; 2005 Jan; 43(1):150-5. PubMed ID: 15634964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of constitutively expressed erm(C) genes selected in vitro by incubation in the presence of the noninducers quinupristin, telithromycin, or ABT-773.
    Schmitz FJ; Petridou J; Astfalk N; Köhrer K; Scheuring S; Schwarz S
    Microb Drug Resist; 2002; 8(3):171-7. PubMed ID: 12363005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.
    Shortridge VD; Zhong P; Cao Z; Beyer JM; Almer LS; Ramer NC; Doktor SZ; Flamm RK
    Antimicrob Agents Chemother; 2002 Mar; 46(3):783-6. PubMed ID: 11850262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro selection of resistance to clindamycin related to alterations in the attenuator of the erm(TR) gene of Streptococcus pyogenes UCN1 inducibly resistant to erythromycin.
    Fines M; Gueudin M; Ramon A; Leclercq R
    J Antimicrob Chemother; 2001 Sep; 48(3):411-6. PubMed ID: 11533008
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.